Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
According to a media release from Adamis Pharmaceuticals, the company has started to enroll patients into a Phase I/IIa clinical trial of APC-100 in men with castration-resistant prostate cancer (CRPC).
Filed under: Drugs in development, Management | Tagged: Adamis, APC-100, casrtation-resistant | Leave a Comment »
According to information on the MSN Money web site, Adamis Pharmaceuticals has received approval from the U.S. Food & Drug Administration of its Investigational New Drug (IND) application and been give approval to initiate a Phase I/IIa clinical trial of APC-100 for the treatment of men with castration-resistant prostate cancer.
Filed under: Drugs in development | Tagged: APC-100 | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site